
Paul V. Ward
Examiner (ID: 13921, Phone: (571)272-2909 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1623, 1622 |
| Total Applications | 2552 |
| Issued Applications | 1846 |
| Pending Applications | 195 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18216392
[patent_doc_number] => 11591314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Process for preparing tetrahydrocarbazole carboxamide compound
[patent_app_type] => utility
[patent_app_number] => 17/101411
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17983
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101411 | Process for preparing tetrahydrocarbazole carboxamide compound | Nov 22, 2020 | Issued |
Array
(
[id] => 18399298
[patent_doc_number] => 11661424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Process for preparing BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/102086
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34518
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102086 | Process for preparing BTK inhibitors | Nov 22, 2020 | Issued |
Array
(
[id] => 18056583
[patent_doc_number] => 20220387669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT
[patent_app_type] => utility
[patent_app_number] => 17/775779
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775779 | CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT | Nov 18, 2020 | Pending |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 18887665
[patent_doc_number] => 11866426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Benzothiazole compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/098880
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31173
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3969
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098880 | Benzothiazole compounds and uses thereof | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 16807777
[patent_doc_number] => 20210130330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => SOLID FORMS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 17/098852
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098852 | Solid forms of Cerdulatinib | Nov 15, 2020 | Issued |
Array
(
[id] => 18075776
[patent_doc_number] => 20220401388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 17/776690
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776690 | Methods for using low-dose colchicine after myocardial infarction | Nov 12, 2020 | Issued |
Array
(
[id] => 18590191
[patent_doc_number] => 11739071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/096349
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26071
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096349 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Nov 11, 2020 | Issued |
Array
(
[id] => 16868430
[patent_doc_number] => 20210161897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/094893
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094893 | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | Nov 10, 2020 | Abandoned |
Array
(
[id] => 16688286
[patent_doc_number] => 20210070762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => SYNTHESIS OF COELENTERAZINE
[patent_app_type] => utility
[patent_app_number] => 17/089573
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089573 | Synthesis of coelenterazine | Nov 3, 2020 | Issued |
Array
(
[id] => 16839920
[patent_doc_number] => 20210147932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR
[patent_app_type] => utility
[patent_app_number] => 17/088119
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088119 | FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR | Nov 2, 2020 | Abandoned |
Array
(
[id] => 17385525
[patent_doc_number] => 20220033377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
[patent_app_type] => utility
[patent_app_number] => 17/086666
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086666 | Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline | Nov 1, 2020 | Abandoned |
Array
(
[id] => 18013263
[patent_doc_number] => 11505545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Anthelmintic quinoline-3-carboxamide derivatives
[patent_app_type] => utility
[patent_app_number] => 17/085880
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 141386
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085880 | Anthelmintic quinoline-3-carboxamide derivatives | Oct 29, 2020 | Issued |
Array
(
[id] => 20226270
[patent_doc_number] => 12414909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Polysaccharide-based gelled foam
[patent_app_type] => utility
[patent_app_number] => 17/772676
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3194
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772676 | Polysaccharide-based gelled foam | Oct 26, 2020 | Issued |
Array
(
[id] => 16612117
[patent_doc_number] => 20210030770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/076081
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076081 | LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS | Oct 20, 2020 | Abandoned |
Array
(
[id] => 16749904
[patent_doc_number] => 20210101913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/076554
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076554 | 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS | Oct 20, 2020 | Abandoned |
Array
(
[id] => 19186231
[patent_doc_number] => 20240165144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE SIGNALING PATHWAYS
[patent_app_type] => utility
[patent_app_number] => 17/769517
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769517 | COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE SIGNALING PATHWAYS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18056504
[patent_doc_number] => 20220387590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED PHOTOLYSIS
[patent_app_type] => utility
[patent_app_number] => 17/765251
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765251 | Photolytic compounds and triplet-triplet annihilation mediated photolysis | Oct 6, 2020 | Issued |